Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025)
Benitec Biopharma (BNTC) reported Free Cash Flow of -$3.7 million for Q4 2025, up 51.97% on a YoY basis from -$2.4 million in Q4 2024, and down 8.82% sequentially from -$3.4 million in Q3 2025.
Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Free Cash Flow data on file, last reported at -$3.7 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 51.97% year-over-year to -$3.7 million; the trailing twelve-month figure through Dec 2025 stood at -$18.4 million (up 15.42% YoY), and the FY2025 full-year result was -$23.6 million, down 20.63% from the prior year.
- Free Cash Flow declined to -$3.7 million in Q4 2025, from -$3.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.0 million in Q1 2021 to a low of -$8.2 million in Q2 2025.
- A 5-year average of -$4.6 million and a median of -$4.2 million in 2021 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow plunged 160.6% in 2021 and soared 51.97% in 2025, its largest moves.
- Tracing BNTC's Free Cash Flow over 5 years: stood at -$3.3 million in 2021, then tumbled by 77.42% to -$5.9 million in 2022, then advanced by 9.48% to -$5.3 million in 2023, then sank by 45.34% to -$7.7 million in 2024, then soared by 51.97% to -$3.7 million in 2025.
- Business Quant data shows BNTC's Free Cash Flow at -$3.7 million in Q4 2025, -$3.4 million in Q3 2025, and -$8.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.70 Mn |
| Dec 31, 2025 | -3.70 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -6.21 Mn |
| Mar 31, 2024 | -6.21 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Sep 30, 2023 | -4.60 Mn |
| Sep 30, 2023 | -4.60 Mn |